Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
5 Biotech Acquisition Targets To Accumulate In 2024
01:05pm, Thursday, 21'st Dec 2023
5 Biotech Acquisition Targets To Accumulate In 2024
3 Cancer-Focused Biotechs That Appear Promising Bets for 2024
10:32am, Thursday, 21'st Dec 2023
With the spotlight on oncology-focused companies in the biotech sector in 2023, we discuss three stocks that have a promising oncology portfolio/pipeline for 2024.
3 Potential Turnaround Stocks to Buy for Big Rewards in 2024
12:39pm, Wednesday, 20'th Dec 2023
This past year was great for investors. Granted, there were some bumps and bruises along the way, with inflation, rising interest rates, a regional banking crisis and troubling geopolitical issues.
5 Stocks to Watch on Their Recent Dividend Hike
09:46am, Wednesday, 20'th Dec 2023
Five stocks that have recently raised dividends are: BMY, PWR, CARR, AVGO, OC.
Bristol Myers Squibb: This Dividend Contender Is A Steal Right Now
03:00pm, Tuesday, 19'th Dec 2023
Bristol Meyers Squibb's stock is down nearly 15% over the past 3 years and currently trades at a price to earnings of less than 15x, indicating it is undervalued. BMY recently announced a deal worth $
Bristol Myers (BMY) Stops Late-Stage Colorectal Cancer Study
12:47pm, Monday, 18'th Dec 2023
Bristol Myers (BMY) decides to discontinue the phase III colorectal cancer study as it was unlikely to meet its primary endpoints upon completion.
Politician with most suspicious trades just bet against this stock
08:06am, Monday, 18'th Dec 2023
In recent times, US Senator Tommy Tuberville has found himself under scrutiny by popular social media accounts, earning the dubious distinction as an American politician with the highest number of sus
7 Stocks with Strong Insider Buying: December 2023
12:35pm, Sunday, 17'th Dec 2023
Many investors are familiar with the idea that there are many reasons why insiders sell shares, but there's only one reason they buy. Insider buying indicates a belief that a company's stock is underv
Is Bristol Myers Squibb Stock a Buy Now?
09:45am, Friday, 15'th Dec 2023
Bristol Myers Squibb is dealing with a dreaded risk drugmakers face: patent cliffs. However, the company's new medicines are slowly but surely rising in importance.
Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024
06:59am, Friday, 15'th Dec 2023
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024.
Bristol Myers Squibb (BMY) Stock Slides as Market Rises: Facts to Know Before You Trade
06:47pm, Thursday, 14'th Dec 2023
In the latest trading session, Bristol Myers Squibb (BMY) closed at $51.47, marking a -0.75% move from the previous day.
Trade Tracker: Jim Lebenthal sells Nike and Bristol-Myers, buys UnitedHealth
01:26pm, Thursday, 14'th Dec 2023
Jim Lebenthal, Cerity Partners chief equity strategist, joins CNBC's "Halftime Report" to discuss his latest trades.
Bristol Myers (BMY) Partners With SystImmune for Oncology Drug
12:47pm, Tuesday, 12'th Dec 2023
Bristol Myers (BMY) is set to co-develop and co-commercialize oncology candidate BL-B01D1 in the United States with SystImmune.
Bristol-Myers Squibb: A Nice Deal For This Bargain Pharma Stock
10:00am, Tuesday, 12'th Dec 2023
Bristol-Myers Squibb announces an up-to-$8.4 billion license deal with SystImmune to bolster its oncology pipeline. The initial payment of $800 million is relatively low for BMY, with potential milest
Bristol Myers, SystImmune to collaborate for cancer drug development
04:32pm, Monday, 11'th Dec 2023
Bristol Myers Squibb said on Monday it will make an upfront payment of $800 million to SystImmune to co-develop and co-commercialize a type of antibody-drug conjugates (ADC) treatment that precisely t
